Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-08-02

FDA Approved: RILUZOLE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)

View source ↗

Summary

The FDA approved a supplemental application for riluzole submitted by Glenmark Pharmaceuticals Inc., USA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Riluzole (riluzole)

Snippet

SUPPL AP for RILUZOLE (RILUZOLE)